- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0028466

Neomatis Pharma Private Limited
About Neomatis Pharma Private Limited
Data last updated:
Neomatis Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2021PTC056653.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Sanjeev Purviya and Rakesh Raghuwanshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.92 Lakh, a growth of 112% compared to the previous year. For the same year it recorded a net profit of ₹34,510 (net margin 0.3%) and EBITDA of ₹3.17 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 112% over three years.
Neomatis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0028466). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Neomatis Pharma
Contact details
Neomatis Pharma Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address203 Fortune Ambience, 4/2 South Tukoganj, Indore, Madhya Pradesh, India – 452001
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neomatis Pharma is manufacturing. In detail, this covers manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 16 | Manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials |
To see the full business activity and turnover split of Neomatis Pharma Private Limited, buy the company report.
Financials of Neomatis Pharma Private Limited
FY 2025 filings availableNeomatis Pharma Private Limited reported revenue of ₹98.92 Lakh (up 112% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 112% over three years, including 112% growth in the latest year. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.17 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹34,510 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.2% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Neomatis Pharma Private Limited, buy the company report.
Board of directors of Neomatis Pharma Private Limited
Neomatis Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Purviya | Director | 12 Jul 2021 | 5 Years 4 Months | Current |
| Rakesh Raghuwanshi Also directs: Clanjewel Lifescience Private Limited | Director | 03 Jan 2024 | 2 Years 10 Months | Current |
| Ramakant Yaduvanshi Also directs: JNV Tubes Private Limited, Valley Plastics Private Limited | Director | 03 Feb 2022 | 4 Years 9 Months | Current |
Peer comparison
Neomatis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Desertwood Interio Private Limited | ₹1.07 Cr (FY 2025) | -52.0% | Vadodara, Gujarat, India | |||
| Leukowitch Chemicals Private Limited | ₹1.05 Cr (FY 2024) | 97.0% | Mumbai, Maharashtra, India | |||
| M A S Furniture Private Limited | ₹1.04 Cr (FY 2025) | 64.0% | Mysore, Karnataka, India | |||
| Plastwood Orchid Private Limited | ₹1.02 Cr (FY 2025) | Patna, Bihar, India | ||||
| Golden Global Corporate Service Private Limited | ₹98.99 Lakh (FY 2025) | 27.0% | Bangalore, Karnataka, India | |||
| Neomatis Pharma Private Limitedthis company | ₹98.92 Lakh (FY 2025) | ₹34,510 | 0.3% | 112.0% | Indore, Madhya Pradesh, India | |
| Shree Computer Forms Private Limited | ₹98.81 Lakh (FY 2025) | -67.0% | Nagpur, Maharashtra, India | |||
| Anantavi Enterprises Private Limited | ₹98.32 Lakh (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Vista Modular System Private Limited | ₹98.09 Lakh (FY 2024) | Gurgaon, Haryana, India | ||||
| Jangid Forever Furniture Private Limited | ₹97.98 Lakh (FY 2025) | -94.0% | Mumbai, Maharashtra, India | |||
| NSP Packaging Private Limited | ₹97.91 Lakh (FY 2025) | 50.0% | Vijayawada, Andhra Pradesh, India |
To see the full peer comparison of Neomatis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neomatis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neomatis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neomatis Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neomatis Pharma Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Rakesh Raghuwanshi was appointed as Director on 03 Jan 2024.
Frequently asked questions
Neomatis Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 July 2021 (5+ years old) and is registered under CIN U24100MP2021PTC056653.
Neomatis Pharma has 3 current directors:
- Sanjeev Purviya - Director
- Rakesh Raghuwanshi - Director
- Ramakant Yaduvanshi - Director
The latest financial statements of Neomatis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Neomatis Pharma is U24100MP2021PTC056653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neomatis Pharma was incorporated on 12 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Neomatis Pharma by revenue are Desertwood Interio Private Limited, Leukowitch Chemicals Private Limited, M A S Furniture Private Limited, Plastwood Orchid Private Limited, Golden Global Corporate Service Private Limited and 5 more, all in the same principal business activity (manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials).
Rakesh Raghuwanshi was appointed as Director on 03 Jan 2024. Ramakant Yaduvanshi was appointed as Director on 03 Feb 2022. Sachin Patil ceased to be Additional Director on 08 Jan 2022. Neomatis Pharma has 5 board changes on record in total.
Yes, Neomatis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0028466).
The registered office of Neomatis Pharma is at 203 Fortune Ambience, 42 South Tukoganj, Indore, Madhya Pradesh, India – 452001.
Neomatis Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Neomatis Pharma is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.

